Clinical Scorecard: Reconceptualizing Osteoarthritis: A Systems Approach to Inflammation Regulation Beyond Cartilage Damage
At a Glance
Category
Detail
Condition
Key Mechanisms
Failure of interdependent synovial regulatory networks including energy-redox imbalance, dysregulated efflux, reduced signaling restraint, and impaired lipid mediator class switching, as part of a systems model.
Target Population
Care Setting
Key Highlights
OA is reframed as a disorder of regulatory failure rather than solely a degenerative disease.
Aging and metabolic dysfunction are central to the pathophysiology of OA.
Current anti-inflammatory therapies may provide symptomatic relief but do not restore regulatory control.
NAD+ decline and mitochondrial inefficiency contribute to synovial inflammation.
The model emphasizes the importance of resolving inflammation rather than just suppressing it.
Guideline-Based Recommendations
Diagnosis
Management
Focus on restoring regulatory mechanisms rather than solely targeting inflammatory mediators, including examples like NAD+ replenishment and enhancing phosphatase activity.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Replenishing NAD+ may reverse aspects of metabolic dysfunction associated with OA, and should be considered in treatment plans.
Clinical Best Practices
Integrate metabolic health assessments into OA management.
Encourage lifestyle modifications such as diet and exercise to address obesity and metabolic disturbances.
Utilize a systems approach to understand and treat OA.
